FNY Managed Accounts LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 3 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
FNY Managed Accounts LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2017$88,000
-99.8%
18,865
-74.8%
0.27%
+15.7%
Q4 2016$35,258,000
-31.9%
75,000
+188.5%
0.24%
+402.1%
Q2 2016$51,740,000
-10.8%
26,000
+207.0%
0.05%
-73.0%
Q3 2014$58,020,0008,4700.17%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q1 2017
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders